Biogen Inc. Common Stock Share Price
NASDAQ: BIIBHealthcare
Live Biogen Inc. Common Stock Share Price Chart
O H L
Biogen Inc. Common Stock Performance Overview
Days Range
▼
$216.07Low
$217.70High
Markets Today
| Previous Close | $216.01 |
|---|---|
| Open | $217.66 |
| Volume | 119,571 |
| Day's Range | $216.07 - $217.70 |
| 52W Range | $135.39 - $225.80 |
| Market Cap | $31.94 B |
Historical Performance
| 1M Returns | +3.28 |
|---|---|
| 3M Returns | +8.73 |
| 6M Returns | +16.58 |
| 1Y Returns | +49.11 |
| 5Y Returns | -28.04 |
| 10Y Returns | -28.83 |
Biogen Inc. Common Stock Fundamentals
| Market Cap | $31.94 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 38.28 |
| PEG Ratio | N/A |
| Revenue | $9.89 B |
| ROE TTM | 0.07 |
| EPS TTM | $5.65 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.69 |
| EBITDA | $2.74 B |
| Profit Margin | 13.07 |
| Market Cap | $31.94 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 38.28 |
| PEG Ratio | N/A |
| Revenue | $9.89 B |
| ROE TTM | 0.07 |
| EPS TTM | $5.65 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.69 |
| EBITDA | $2.74 B |
| Profit Margin | 13.07 |
Biogen Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $2.43 B | $2.65 B | $2.53 B | $2.28 B | $2.48 B | $2.74 B |
| Gross Profit + | $1.80 B | $2.04 B | $1.86 B | $1.78 B | $1.82 B | $1.96 B |
| Operating Income | $379.60 M | $792.70 M | $591.40 M | $98.40 M | $397.40 M | $150.90 M |
| EBITDA | $598.10 M | $999.50 M | $806.60 M | $329.70 M | $609.70 M | $554.90 M |
| Interest Expense | $0 | -$72.60 M | $0 | $0 | $0 | -$82.30 M |
| Depreciation | $218.50 M | $206.80 M | $215.20 M | $231.30 M | $212.30 M | $404.00 M |
| Income Before Tax | $311.20 M | $744.00 M | $557.30 M | -$56.00 M | $377.70 M | $132.40 M |
| Income Tax Expense | $70.70 M | $109.20 M | $90.80 M | -$7.10 M | $58.20 M | $34.90 M |
| Net Income + | $240.50 M | $634.80 M | $466.50 M | -$48.90 M | $319.50 M | $97.50 M |
| Net Profit Margin | 9.89% | 24% | 18.4% | -2.15% | 12.89% | 3.56% |
Biogen Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $100.00 K | $100.00 K | $100.00 K | $100.00 K | $100.00 K | $100.00 K |
| Reserve & Surplus | $19.33 B | $19.90 B | $20.39 B | $20.37 B | $20.73 B | $20.84 B |
| Non-Current Liabilities | $5.76 B | $7.51 B | $7.71 B | $7.83 B | $7.83 B | $9.32 B |
| Current Liabilities | $5.30 B | $3.18 B | $3.29 B | $3.35 B | $3.00 B | $3.92 B |
| Total Liabilities | $11.05 B | $10.70 B | $11.00 B | $11.18 B | $10.83 B | $13.24 B |
| Fixed Assets | $12.72 B | $12.57 B | $12.41 B | $12.23 B | $12.07 B | $16.51 B |
| Current Assets | $7.63 B | $7.97 B | $8.94 B | $8.97 B | $9.19 B | $7.31 B |
| Total Assets | $28.03 B | $28.33 B | $29.21 B | $29.44 B | $29.48 B | $32.09 B |
Biogen Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $240.50 M | $634.80 M | $466.50 M | -$48.90 M | $319.50 M | $97.50 M |
| Operating Cash Flow | $259.30 M | $160.90 M | $1.27 B | $511.90 M | $645.50 M | $448.90 M |
| Investing Cash Flow | -$47.30 M | -$57.00 M | -$35.10 M | -$1.23 B | -$209.50 M | -$3.84 B |
| Financing Cash Flow | -$23.00 M | -$11.70 M | -$130.20 M | -$137.00 M | -$43.80 M | $1.30 B |
| Change in Cash | $189.00 M | $92.20 M | $1.11 B | -$856.80 M | $392.20 M | -$2.09 B |
Biogen Inc. Common Stock Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $1.01T | 394.49% | 38.13 | 31.67% | 0.61% |
 | $7.85B | 20.51% | 0.00 | -40.41% | 0.00% |
 | $203.09B | 71.55% | 23.33 | 20.98% | 2.68% |
 | $130.44B | 172.58% | 29.94 | 32.94% | 0.00% |
 | $427.64M | -89.31% | 0.00 | -2520.57% | 0.00% |
 | $57.40B | -66.14% | 0.00 | -145.16% | 0.00% |
 | $181.41B | 106.23% | 0.00 | 28.90% | 2.24% |
 | $130.18B | 3.74% | 14.03 | 14.64% | 3.95% |
 | $464.82B | 143.67% | 74.40 | 6.92% | 2.63% |
 | $3.26B | -62.03% | 0.00 | NA | 0.00% |
Biogen Inc. Common Stock Return Calculator
The Biogen Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$7,172
Invested Amount$10,000
Est. Returns$-2,828
About Biogen Inc. Common Stock
Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).
Popular Stocks
FAQs
What is the share price of Biogen Inc. Common Stock today?
Biogen Inc. Common Stock (BIIB) share price as of September 17, 2026 is $215.29. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Biogen Inc. Common Stock?
Yes, Indian Investors can invest in the Biogen Inc. Common Stock (BIIB) Share by opening an international trading account with Angel One.
How can I purchase Biogen Inc. Common Stock shares in India?
Purchasing Biogen Inc. Common Stock (BIIB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Biogen Inc. Common Stock (BIIB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Biogen Inc. Common Stock?
Yes, you can purchase fractional shares of Biogen Inc. Common Stock (BIIB) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Biogen Inc. Common Stock?
The market capitalization of Biogen Inc. Common Stock on September 17, 2026, is $31.94 B.
In which sector Biogen Inc. Common Stock belongs?
Biogen Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Biogen Inc. Common Stock stocks?
In order to invest in Biogen Inc. Common Stock (BIIB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
